NSN 6505-01-654-2233, 6505016542233
SARGRAMOSTIM FOR INJECTION

Federal Supply Classification: FSC 6505 - Drugs and Biologicals
National Item Identification Number: NIIN 016542233
Codification Country: United States
Item Name Code: INC 47171
Criticality: (X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code: (P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.

Availability: Request Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know

CALL ABOUT NSN 6505-01-654-2233

Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

REQUEST QUOTE for 6505-01-654-2233

Have a list that needs to be quoted? Upload it here.

Upload a List

DLMS^® Summary

National Stock Number 6505-01-654-2233

National Stock Number (NSN) 6505-01-654-2233, or NIIN 016542233, (sargramostim for injection) was assigned April 21, 2016 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.

There are 4 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 2 suppliers. Today, 2 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 2 suppliers are deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over 5 years.

Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Apr 22, 2016, this NSN's acquisition method was noted as: Not established. Not established.

This NSN is assigned to Item Name Code (INC) 47171. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505016542233 does not contain precious metals.

This information was last updated on Jul 01, 2025.

Technical Characteristics

ACTIVE MEDICAMENT MEDICINAL STRENGTH: (AKJA) 250.00 MICROGRAMS SARGRAMOSTIM ACTIVE INGREDIENT
ADMINISTRATION: (CSGS) SUBCUTANEOUS AND INTRAVENOUS INFUSION
FEATURES PROVIDED: (CBBL) STERILE
PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) LEUKINE (SARGRAMOSTIM) INJ, 250 MCG PER VIAL, 5'S
PHYSICAL FORM: (AGXW) FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: (CRLK) 250.00 MICROGRAMS
PRIMARY CONTAINER TYPE: (CQCT) VIAL
PROTECTIVE STORAGE FEATURE: (AJCN) REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
SPECIAL FEATURES: (FEAT) SARGRAMOSTIM 250 MCG PER VIAL; CONTAINS 250 MCG OF PRESERVATIVE-FREE LYOPHILIZED SARGRAMOSTIM; PACKAGE OF 5 VIALS; SHOULD BE REFRIGIRATED BETWEEN 2-8DEG (36-46 F); DO NOT FREEZE OR SHAKE; FOR SUBCUTANEOUS INJECTION OR IV INFUSION
USUAL DOSE: (CSLZ) 250 MCG/M2/DAY FOR 14 DAYS AS A 2-HOUR IV INFUSION; THE DOSE CAN BE REPEEATED AFTER 7 DAYS OFF THERAPY IF ENGRAFTMENT HAS NOT OCCURRED; IF ENGRAFTMENT STILL HAS NOT OCCURRED, A THIRD COURSE OF 500 MCG/M2/DAY FOR 14 DAYS MAY BE TRIED AFTER ANOTHER 7 DAYS OFF THERAPY
III USUAL DOSE: (CSLZ) 250 MCG/M2/DAY FOR 14 DAYS AS A 2-HOUR IV INFUSION; THE DOSE CAN BE REPEEATED AFTER 7 DAYS OFF THERAPY IF ENGRAFTMENT HAS NOT OCCURRED; IF ENGRAFTMENT STILL HAS NOT OCCURRED, A THIRD COURSE OF 500 MCG/M2/DAY FOR 14 DAYS MAY BE TRIED AFTER ANOTHER 7 DAYS OFF THERAPY
III PROTECTIVE STORAGE FEATURE: (AJCN) REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
III PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) LEUKINE (SARGRAMOSTIM) INJ, 250 MCG PER VIAL, 5'S